Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 2Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Nasopharyngeal Carcinoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Biphenotypic, Acute 1Down Syndrome 1Burkitt Lymphoma 1

Interventions

pegaspargase 4Vincristine 4Doxorubicin 4Cytarabine 4Cyclophosphamide 4merphos 3dexamethasone acetate 3dexamethasone 21-phosphate 3azathiopurine 3auricularum 3Thioguanine 3Radiotherapy 3Methotrexate 3Mercaptopurine 3Leucovorin 3Dexamethasone 3Daunorubicin 3Calcium Dobesilate 3Asparaginase 3nelarabine 2liposomal amphotericin B 2calaspargase pegol 2Radiation 2Prednisone 2Levofloxacin 2Ifosfamide 2Hydrocortisone 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Leyk × Clear all
NCT00408005 2025-04-20

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

National Cancer Institute (NCI)

Phase 3 Completed
1,895 enrolled 16 charts
LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡